Skip to main content
OpenTrials

Clinical trial condition

DLBCL

Explore clinical trials studying DLBCL. Study availability and eligibility vary by location and protocol.

51 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

DLBCL trial results

Active, Not Recruiting

First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma

NCT03625037

Conditions
Aggressive B-cell Non-Hodgkin Lymphoma (aNHL), Chronic Disease, DLBCL, +26 more
Locations
  • Arizona Mayo Clinic Phoenix, Arizona, United States
  • University of California at San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 85 locations
View Trial Details
Active, Not Recruiting

Ibrutinib + R-CHOP Followed by Ibrutinib Maintenance

NCT03731234

Conditions
DLBCL
Locations
  • Ospedale di Castelfranco Veneto - Oncoematologia IOV Castelfranco Veneto, Treviso, Italy
  • A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C. Ematologia Alessandria, Italy
  • Università Politecnica delle Marche- Clinica di Ematologia Ancona, Italy
  • Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico Avellino, Italy
View all 39 locations
View Trial Details
Active, Not Recruiting

P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

NCT06014762

Conditions
DLBCL, DLBCL - Diffuse Large B Cell Lymphoma, DLBCL Arising From Follicular Lymphoma, +21 more
Locations
  • Loma Linda University Cancer Center Loma Linda, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Advent Health Orlando Orlando, Florida, United States
  • Indiana University Indianapolis, Indiana, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Study of Oral MRT-2359 in Selected Cancer Patients

NCT05546268

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +38 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Kansas Cancer Center Lawrence, Kansas, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

NCT04072458

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +40 more
Locations
  • Georgia Cancer Center Augusta, Georgia, United States
  • New York Medical College / Westchester Medical Center Valhalla, New York, United States
  • Sarah Cannon Research Institute/Tennesee Oncology Nashville, Tennessee, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details

Related conditions